NEW YORK (GenomeWeb News) – Helicos Biosciences reported after the close of the market Monday that its first quarter revenues fell 53 percent as the firm continues to seek additional funds to keep its operations afloat.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.